These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 2533990

  • 1. Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa.
    Kaye WH, Berrettini WH, Gwirtsman HE, Gold PW, George DT, Jimerson DC, Ebert MH.
    Psychopharmacol Bull; 1989; 25(3):433-8. PubMed ID: 2533990
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide abnormalities in anorexia nervosa.
    Kaye WH.
    Psychiatry Res; 1996 Apr 16; 62(1):65-74. PubMed ID: 8739116
    [Abstract] [Full Text] [Related]

  • 3. The role of neuropeptides in the disturbed control of appetite and hormone secretion in eating disorders.
    Baranowska B, Wolinska-Witort E, Wasilewska-Dziubinska E, Roguski K, Martynska L, Chmielowska M.
    Neuro Endocrinol Lett; 2003 Dec 16; 24(6):431-4. PubMed ID: 15073570
    [Abstract] [Full Text] [Related]

  • 4. Prospective evaluation of leptin and neuropeptide Y (NPY) serum levels in girls with anorexia nervosa.
    Oświecimska J, Ziora K, Geisler G, Broll-Waśka K.
    Neuro Endocrinol Lett; 2005 Aug 16; 26(4):301-4. PubMed ID: 16136022
    [Abstract] [Full Text] [Related]

  • 5. Behavioral neuroendocrinology and treatment of anorexia nervosa.
    Södersten P, Nergårdh R, Bergh C, Zandian M, Scheurink A.
    Front Neuroendocrinol; 2008 Oct 16; 29(4):445-62. PubMed ID: 18602416
    [Abstract] [Full Text] [Related]

  • 6. [Selected issues of biological aspects of eating disorders].
    Włodarczyk-Bisaga K, Bisaga A.
    Psychiatr Pol; 1994 Oct 16; 28(5):579-91. PubMed ID: 7991711
    [Abstract] [Full Text] [Related]

  • 7. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
    Liu JP, Clarke IJ, Funder JW, Engler D.
    J Clin Invest; 1994 Apr 16; 93(4):1439-50. PubMed ID: 8163648
    [Abstract] [Full Text] [Related]

  • 8. [Neuroendocrine disorders in anorexia nervosa--primary or secondary?].
    Støving RK, Hansen-Nord M, Hangaard J, Hagen C.
    Ugeskr Laeger; 1996 Dec 02; 158(49):7052-6. PubMed ID: 8999610
    [Abstract] [Full Text] [Related]

  • 9. Role of beta-endorphin, corticotropin-releasing hormone, and autonomic nervous system in mediation of the effect of chronic ethanol on natural killer cell cytolytic activity.
    Boyadjieva N, Advis JP, Sarkar DK.
    Alcohol Clin Exp Res; 2006 Oct 02; 30(10):1761-7. PubMed ID: 17010143
    [Abstract] [Full Text] [Related]

  • 10. Corticotropin-releasing hormone: possible role in eating disorders.
    Krahn DD, Gosnell BA.
    Psychiatr Med; 1989 Oct 02; 7(4):235-45. PubMed ID: 2690192
    [Abstract] [Full Text] [Related]

  • 11. Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety.
    Thorsell A.
    Exp Biol Med (Maywood); 2010 Oct 02; 235(10):1163-7. PubMed ID: 20881320
    [Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor-alpha: is there a continuum of liability between stress, anxiety states and anorexia nervosa?
    Holden RJ, Pakula IS.
    Med Hypotheses; 1999 Feb 02; 52(2):155-62. PubMed ID: 10340296
    [Abstract] [Full Text] [Related]

  • 13. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
    J Psychiatr Res; 2007 Feb 02; 41(1-2):131-43. PubMed ID: 16455105
    [Abstract] [Full Text] [Related]

  • 14. Eating behavior in anorexia nervosa--an excess of both orexigenic and anorexigenic signalling?
    Inui A.
    Mol Psychiatry; 2001 Nov 02; 6(6):620-4. PubMed ID: 11673789
    [Abstract] [Full Text] [Related]

  • 15. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.
    Kaye WH, Gwirtsman HE, George DT, Ebert MH, Jimerson DC, Tomai TP, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1987 Feb 02; 64(2):203-8. PubMed ID: 3491830
    [Abstract] [Full Text] [Related]

  • 16. The role of leptin and orexins in the dysfunction of hypothalamo-pituitary-gonadal regulation and in the mechanism of hyperactivity in patients with anorexia nervosa.
    Baranowska B, Baranowska-Bik A, Bik W, Martynska L.
    Neuro Endocrinol Lett; 2008 Feb 02; 29(1):37-40. PubMed ID: 18283238
    [Abstract] [Full Text] [Related]

  • 17. Neuropeptide Y facilitates activity-based-anorexia.
    Nergårdh R, Ammar A, Brodin U, Bergström J, Scheurink A, Södersten P.
    Psychoneuroendocrinology; 2007 Jun 02; 32(5):493-502. PubMed ID: 17467917
    [Abstract] [Full Text] [Related]

  • 18. Role of hypothalamic neuropeptide Y and orexigenic peptides in anorexia associated with experimental colitis in the rat.
    Ballinger AB, Williams G, Corder R, El-Haj T, Farthing MJ.
    Clin Sci (Lond); 2001 Feb 02; 100(2):221-9. PubMed ID: 11171292
    [Abstract] [Full Text] [Related]

  • 19. [Functional disturbances of the hypothalamus in patients with anorexia nervosa].
    Pałasz A.
    Psychiatr Pol; 2004 Feb 02; 38(6):1001-9. PubMed ID: 15779664
    [Abstract] [Full Text] [Related]

  • 20. Cancer anorexia-cachexia syndrome: are neuropeptides the key?
    Inui A.
    Cancer Res; 1999 Sep 15; 59(18):4493-501. PubMed ID: 10493494
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.